PubMed Health⌕ Search

Biomedical subjects

M Février

Publications and source records attributed to M Février.

20 records · Page 2Linked to original sources

Modulation of helper T-cell activity by macrophage products.

Mouse spleen cells cultured with muramyl dipeptide (MDP) release factors (SMF, or splenic macrophage factors) which enhance the in vitro plaque-forming cell (PFC) response to the T-dependent antigen SRBC (sheep red blood cells). The present study substantiates previous results and shows that T cells were the target cells of such conditioned medium. We investigated which T-cell subpopulations had their activities modified by these factors. In the presence of SMF, T cells educated in vivo elicited enhanced PFC responses to both specific educating antigen and an unrelated antigen (during a bystander response). This could indicate that SMF potentiates Th2-cell activity. Moreover, in vivo matured but unprimed thymocytes, which are unable to cooperate with virgin B cells in an in vitro T-dependent response, are able to do so when SMF is added in cooperative cultures. It is concluded that MDP-conditioned medium allows the maturation/differentiation of a subset of T cells to the point where they can be stimulated by the antigen.

Acetylmuramyl-Alanyl-Isoglutamine↗

Induction of tolerance in adult guinea-pigs by two antigen dosage levels and by antigenic competition.

The effect of prior injection of increasing doses of dinitrophenylated bovine serum albumin (DNP-BSA) mixed in Freund's complete (FCA) or incomplete (IFA) adjuvants on the antibody response to a subsequent challenge with an optimal immunizing dose of DNP-BSA in FCA has been examined and compared with the effect of competition with the unrelated antigen bovine gamma-globulin (BGG). An unresponsive state was induced by pretreatments with either a minimal dose of antigen, a large antigen excess or a competitive mixture in FCA. The specificity of this unresponsiveness was ascertained by the normal response of pretreated animals to the unrelated antigen arsanilic-human albumin (ARS-HSA). Prior injection of either a minimal dose (0,2 mug), an antigen excess (20 mg) of DNP-BSA or an optimal dose (20 mug) of DNP-BSA mixed with an excess of BGG, incorporated in IFA, also induced a specific tolerance to DNP-BSA. The former treatment induced a low zone tolerance whereas both later treatments induced a high zone tolerance.

Animals↗